Skip to content

blood DNA methylation before and after rTMS

Blood DNA methylation before and after repetitive transcranial magnetic stimulation therapy for depressed patients.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1060230067
Enrollment
50
Registered
2023-10-17
Start date
2023-10-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive disorder

Interventions

None listed

Sponsors

Iwata Masaaki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Men and women who are scheduled to undergo rTMS at the institution where the research will be conducted (2) Persons who have obtained consent for this research from the research subjects themselves.

Exclusion criteria

Exclusion criteria: (1) Patients who refuse to allow the use of data collected from their medical information records. (2) Other patients who are deemed inappropriate as research subjects by the principal investigator.

Design outcomes

Primary

MeasureTime frame
HAM-D, blood DNA methylation

Contacts

Public ContactTakehiko Yamanashi

Tottori University Hospital

yamatake@tottori-u.ac.jp+81-859-38-6547

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026